Current causes of death in familial hypercholesterolemia

Abstract Background Familial hypercholesterolemia (FH) is a codominant autosomal disease characterized by high low-density lipoprotein cholesterol (LDLc) and a high risk of premature cardiovascular disease (CVD). The molecular bases have been well defined, and effective lipid lowering is possible. T...

Full description

Bibliographic Details
Main Authors: Victoria Marco-Benedí, Ana M. Bea, Ana Cenarro, Estíbaliz Jarauta, Martín Laclaustra, Fernando Civeira
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Lipids in Health and Disease
Subjects:
Online Access:https://doi.org/10.1186/s12944-022-01671-5
_version_ 1817968094964875264
author Victoria Marco-Benedí
Ana M. Bea
Ana Cenarro
Estíbaliz Jarauta
Martín Laclaustra
Fernando Civeira
author_facet Victoria Marco-Benedí
Ana M. Bea
Ana Cenarro
Estíbaliz Jarauta
Martín Laclaustra
Fernando Civeira
author_sort Victoria Marco-Benedí
collection DOAJ
description Abstract Background Familial hypercholesterolemia (FH) is a codominant autosomal disease characterized by high low-density lipoprotein cholesterol (LDLc) and a high risk of premature cardiovascular disease (CVD). The molecular bases have been well defined, and effective lipid lowering is possible. This analysis aimed to study the current major causes of death of genetically defined heterozygous familial hypercholesterolemia (heFH). Methods A case‒control study was designed to analyse life-long mortality in a group of heFH and control families. Data from first-degree family members of cases and controls (nonconsanguineous cohabitants), including deceased relatives, were collected from a questionnaire and review of medical records. Mortality was compared among heFH patients, nonheFH patients, and nonconsanguineous family members. Results A total of 813 family members were analysed, 26.4% of whom were deceased. Among the deceased, the mean age of death was 69.3 years in heFH individuals, 73.5 years in nonheFH individuals, and 73.2 years in nonconsanguineous individuals, without significant differences. CVD was the cause of death in 59.7% of heFH individuals, 37.7% of nonheFH individuals, and 37.4% of nonconsanguineous individuals (P = 0.012). These differences were greater after restricting the analyses to parents. The hazard ratio of dying from CVD was 2.85 times higher (95% CI, (1.73–4.69) in heFH individuals than in individuals in the other two groups (non-FH and nonconsanguineous), who did not differ in their risk. Conclusions CVD mortality in heFH individuals is lower and occurs later than that described in the last century but is still higher than that in non-FH individuals. This improved prognosis of CVD risk is not associated with changes in non-CVD mortality.
first_indexed 2024-04-13T20:03:27Z
format Article
id doaj.art-d895cb040eaa42aa834a09f4b5eb070e
institution Directory Open Access Journal
issn 1476-511X
language English
last_indexed 2024-04-13T20:03:27Z
publishDate 2022-08-01
publisher BMC
record_format Article
series Lipids in Health and Disease
spelling doaj.art-d895cb040eaa42aa834a09f4b5eb070e2022-12-22T02:32:07ZengBMCLipids in Health and Disease1476-511X2022-08-012111910.1186/s12944-022-01671-5Current causes of death in familial hypercholesterolemiaVictoria Marco-Benedí0Ana M. Bea1Ana Cenarro2Estíbaliz Jarauta3Martín Laclaustra4Fernando Civeira5Hospital Universitario Miguel Servet, IIS Aragón, CIBERCVHospital Universitario Miguel Servet, IIS Aragón, CIBERCVUnidad de Lípidos, Hospital Universitario Miguel ServetHospital Universitario Miguel Servet, IIS Aragón, CIBERCVHospital Universitario Miguel Servet, IIS Aragón, CIBERCVHospital Universitario Miguel Servet, IIS Aragón, CIBERCVAbstract Background Familial hypercholesterolemia (FH) is a codominant autosomal disease characterized by high low-density lipoprotein cholesterol (LDLc) and a high risk of premature cardiovascular disease (CVD). The molecular bases have been well defined, and effective lipid lowering is possible. This analysis aimed to study the current major causes of death of genetically defined heterozygous familial hypercholesterolemia (heFH). Methods A case‒control study was designed to analyse life-long mortality in a group of heFH and control families. Data from first-degree family members of cases and controls (nonconsanguineous cohabitants), including deceased relatives, were collected from a questionnaire and review of medical records. Mortality was compared among heFH patients, nonheFH patients, and nonconsanguineous family members. Results A total of 813 family members were analysed, 26.4% of whom were deceased. Among the deceased, the mean age of death was 69.3 years in heFH individuals, 73.5 years in nonheFH individuals, and 73.2 years in nonconsanguineous individuals, without significant differences. CVD was the cause of death in 59.7% of heFH individuals, 37.7% of nonheFH individuals, and 37.4% of nonconsanguineous individuals (P = 0.012). These differences were greater after restricting the analyses to parents. The hazard ratio of dying from CVD was 2.85 times higher (95% CI, (1.73–4.69) in heFH individuals than in individuals in the other two groups (non-FH and nonconsanguineous), who did not differ in their risk. Conclusions CVD mortality in heFH individuals is lower and occurs later than that described in the last century but is still higher than that in non-FH individuals. This improved prognosis of CVD risk is not associated with changes in non-CVD mortality.https://doi.org/10.1186/s12944-022-01671-5Heterozygous familial hypercholesterolemia phenotypeParental-offspringCardiovascular disease death
spellingShingle Victoria Marco-Benedí
Ana M. Bea
Ana Cenarro
Estíbaliz Jarauta
Martín Laclaustra
Fernando Civeira
Current causes of death in familial hypercholesterolemia
Lipids in Health and Disease
Heterozygous familial hypercholesterolemia phenotype
Parental-offspring
Cardiovascular disease death
title Current causes of death in familial hypercholesterolemia
title_full Current causes of death in familial hypercholesterolemia
title_fullStr Current causes of death in familial hypercholesterolemia
title_full_unstemmed Current causes of death in familial hypercholesterolemia
title_short Current causes of death in familial hypercholesterolemia
title_sort current causes of death in familial hypercholesterolemia
topic Heterozygous familial hypercholesterolemia phenotype
Parental-offspring
Cardiovascular disease death
url https://doi.org/10.1186/s12944-022-01671-5
work_keys_str_mv AT victoriamarcobenedi currentcausesofdeathinfamilialhypercholesterolemia
AT anambea currentcausesofdeathinfamilialhypercholesterolemia
AT anacenarro currentcausesofdeathinfamilialhypercholesterolemia
AT estibalizjarauta currentcausesofdeathinfamilialhypercholesterolemia
AT martinlaclaustra currentcausesofdeathinfamilialhypercholesterolemia
AT fernandociveira currentcausesofdeathinfamilialhypercholesterolemia